The board of directors of Alembic Pharmaceuticals on Wednesday approved the issue of unsecured, listed, rated, redeemable, non-convertible debentures of up to ₹300 crore on private placement basis. Shares of Alembic Pharma edged down 0.06 per cent at ₹501.75 on the BSE.
Company news: Alembic Pharmaceuticals
Published on
June 12, 2019 17:01